SCOTT SCHLACKMAN
CIK 1645617 · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$502.1K
Companies
1
Total Filings
26
Lifetime Open-Market Net
-$1.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MED | Director | 42,228 | $11.89 | $502.1K | -$1.56M | 26 | 2026-05-28 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-09 | MED | Buy (P) | +9 | $1.1K | EDGAR |
| 2022-11-10 | MED | Buy (P) | +10 | $1.1K | EDGAR |
| 2022-08-10 | MED | Grant (A) | +7 | $1.1K | EDGAR |
| 2022-06-21 | MED | Grant (A) | +1,448 | $0 | EDGAR |
| 2021-06-30 | MED | Grant (A) | +669 | $0 | EDGAR |
| 2021-06-07 | MED | Grant (A) | +669 | $0 | EDGAR |
| 2021-05-21 | MED | Sell (S) | −1,000 | -$310.2K | EDGAR |
| 2020-06-18 | MED | Grant (A) | +1,699 | $0 | EDGAR |
| 2020-06-08 | MED | Mixed | −1,619 | -$293.9K | EDGAR |
| 2019-03-12 | MED | Sell (S) | −2,000 | -$261.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.